SCHEMBL45385

SCHEMBL45385

[CH2]CN(C)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL442903 0.75
SCHEMBL10559774 0.75 USP2 (0.34)
SCHEMBL10558323 0.73 USP2 (0.33)
SCHEMBL9814035 0.72 TSHR (0.47)
SCHEMBL17517389 0.72
SCHEMBL28816217 0.71
SCHEMBL27990142 0.69
SCHEMBL5522835 0.69
SCHEMBL28829 0.69
SCHEMBL15161810 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9714560-B2 Protected scale inhibitors and methods relating thereto HALLIBURTON ENERGY SERVICES, INC. (US) 2017-07-25 US claimed
US-20140038181-A1 CHEMICALLY SUBSTITUTED THERMOSENSITIVE PROBES AND COFACTORS FOR HOT START LIGATION TRILINK BIOTECHNOLOGIES, INC. 2014-02-06 US claimed
US-8361753-B2 Phosphotriester-modified oligonucleotide primers for nucleic acid amplification TRILINK BIOTECHNOLOGIES, INC. (US) 2013-01-29 US claimed
WO-2012094343-A1 CHEMICALLY SUBSTITUTED THERMOSENSITIVE PROBES AND COFACTORS FOR HOT START LIGATION TRILINK BIOTECHNOLOGIES (US) 2012-07-12 WO claimed
EP-2032714-B1 CHEMICALLY MODIFIED OLIGONUCLEOTIDE PRIMERS FOR NUCLEIC ACID AMPLIFICATION TRILINK BIOTECHNOLOGIES (US) 2011-03-16 EP claimed
US-7705034-B2 Vinylogous acid derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-27 US claimed
EP-2074090-A1 VINYLOGOUS ACIDS DERIVATIVES AS CHYMASE INHIBITORS F. Hoffmann-Roche AG (CH) 2009-07-01 EP claimed
EP-2032714-A1 CHEMICALLY MODIFIED OLIGONUCLEOTIDE PRIMERS FOR NUCLEIC ACID AMPLIFICATION TriLink BioTechnologies (US) 2009-03-11 EP claimed
US-20080096953-A1 Vinylogous acid derivatives HOFFMANN-LA ROCHE INC. 2008-04-24 US claimed
WO-2008043698-A1 VINYLOGOUS ACIDS DERIVATIVES AS CHYMASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2008-04-17 WO claimed
WO-2007139723-A1 CHEMICALLYMODIFIED OLIGONUCLEOTIDE PRIMERS FOR NUCLEIC ACID AMPLIFICATION TRILINK BIOTECHNOLOGIES (US) 2007-12-06 WO claimed
US-20070281308-A1 CHEMICALLY MODIFIED OLIGONUCLEOTIDE PRIMERS FOR NUCLEIC ACID AMPLIFICATION TRILINK BIOTECHNOLOGIES, LLC 2007-12-06 US claimed
US-20240229026-A1 CHIRAL CONTROL WAVE LIFE SCIENCES LTD. (SG) 2024-07-11 US disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
EP-4396354-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF Wave Life Sciences Ltd. (SG) 2024-07-10 EP disclosed
WO-2024130217-A1 STAPLED PEPTIDES AND METHODS THEREOF FOG PHARMACEUTICALS, INC. (US) 2024-06-20 WO disclosed
US-6689844-B2 ETHYLENICALLY UNSATURATED MONOMERS ARE POLYMERIZED BY INITIATORS WITH A TRANSFERABLE HALOGEN AND TRANSITION METAL CATALYSTS IN THE PRESENCE OF LIGANDS WHICH FORM A COORDINATION COMPOUND, AND REACTING WITH A NITROGEN COMPOUND ROHMAX ADDITIVES GMBH (DE) 2004-02-10 US disclosed
US-20020188081-A1 Process for synthesis of polymer compositions with reduced halogen content, polymer composition with reduced halogen content as well as use of this composition ROHMAX ADDITIVES GMBH KIRSCHENALLEE (DE) 2002-12-12 US disclosed
US-6348554-B1 TRANSITION METAL COORDINATION CATALYST IS OXIDIZED AFTER ADDITION POLYMERIZATION AND SEPARATED BY FILTRATION; CONTAINS SOLVENT WITH LOW DIELECTRIC CONSTANT; CATALYSIS ROHMAX ADDITIVES GMBH (DE) 2002-02-19 US disclosed
US-4211696-A Disperse monoazo dyestuffs derived from 3,5-dinitro-2-amino thiophene as disazo component and an arylamine coupling component IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-07-08 US disclosed